Gebelikte Antifosfolipid Sendromunun Etkileri ve Yönetimi

Practice Bulletin No. 132: Antiphospholipid syndrome. Obstetrics and gynecology. 2012;120(6):1514-21.
Lockshin MD. Antiphospholipid antibody. Babies, blood clots, biology. Jama. 1997;277(19):1549-51.
Shehata H, Ali A, Silva-Edge M, Haroon S, Elfituri A, Viswanatha R, et al. Thrombophilia screening in women with recurrent first trimester miscarriage: is it time to stop testing? - a cohort study and systematic review of the literature. BMJ open. 2022;12(7):e059519.
Khamashta MA, Amigo M-CJR. Antiphospholipid syndrome: overview of pathogenesis, diagnosis, and management. 2015:1144-52.
Lockshin MD. Update on antiphospholipid syndrome. Bulletin of the NYU hospital for joint diseases. 2008;66(3):195-7.
Creagh MD, Greaves M. Lupus anticoagulant. Blood reviews. 1991;5(3):162-7.
Jayakody Arachchillage D, Greaves M. The chequered history of the antiphospholipid syndrome. British journal of haematology. 2014;165(5):609-17.
Pengo V, Bison E, Banzato A, Zoppellaro G, Jose SP, Denas G. Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT). Methods in molecular biology (Clifton, NJ). 2017;1646:169-76.
Triplett DA. Antiphospholipid antibodies. Archives of pathology & laboratory medicine. 2002;126(11):1424-9.
Erkan D, Derksen WJ, Kaplan V, Sammaritano L, Pierangeli SS, Roubey R, et al. Real world experience with antiphospholipid antibody tests: how stable are results over time? Annals of the rheumatic diseases. 2005;64(9):1321-5.
Wong RC. Consensus guidelines for anticardiolipin antibody testing. Thrombosis research. 2004;114(5-6):559-71.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of thrombosis and haemostasis : JTH. 2006;4(2):295-306.
Favaloro EJ, Wong RCJP. Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines. 2014;46(6):481-95.
de Laat B, Derksen RH, van Lummel M, Pennings MT, de Groot PG. Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. Blood. 2006;107(5):1916-24.
Karska-Basta I, Kubicka-Trząska A, Romanowska-Dixon B, Undas AJKOAOP. Thrombophilia–a risk factor of retinal vein occlusion? 2013;115(1):29-33.
Garcia D, Erkan D. Diagnosis and Management of the Antiphospholipid Syndrome. The New England journal of medicine. 2018;378(21):2010-21.
Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis and rheumatism. 1999;42(7):1309-11.
Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, et al. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis & rheumatology (Hoboken, NJ). 2023;75(10):1687-702.
Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GR. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Archives of internal medicine. 1986;146(11):2153-6.
Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. The Journal of rheumatology. 1986;13(3):486-9.
Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. The New England journal of medicine. 1995;332(15):993-7.
Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstetrics and gynecology. 1994;83(3):372-7.
Malm J, Laurell M, Nilsson IM, Dahlbäck B. Thromboembolic disease--critical evaluation of laboratory investigation. Thrombosis and haemostasis. 1992;68(1):7-13.
Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. Jama. 2006;295(9):1050-7.
Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstetrics and gynecology. 1992;80(4):614-20.
Branch DW, Silver RM, Porter TF. Obstetric antiphospholipid syndrome: current uncertainties should guide our way. Lupus. 2010;19(4):446-52.
Yamada H, Atsumi T, Kobashi G, Ota C, Kato EH, Tsuruga N, et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. Journal of reproductive immunology. 2009;79(2):188-95.
do Prado AD, Piovesan DM, Staub HL, Horta BLJO, Gynecology. Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis. 2010;116(6):1433-43.
Cervera R, Serrano R, Pons-Estel G, Ceberio-Hualde L, Shoenfeld Y, De Ramón E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. 2015;74(6):1011-8.
Clark EA, Silver RM, Ware Branch DJCrr. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? 2007;9(3):219-25.
Canti V, Del Rosso S, Tonello M, Lucianò R, Hoxha A, Coletto LA, et al. Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia. The Journal of rheumatology. 2018;45(9):1263-72.
Yamada H, Atsumi T, Kobashi G, Ota C, Kato EH, Tsuruga N, et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. 2009;79(2):188-95.
Oshiro BT, Silver RM, Scott JR, Yu H, Branch DWJO, Gynecology. Antiphospholipid antibodies and fetal death. 1996;87(4):489-93.
Bats AS, Lejeune V, Cynober E, Safar E, Gonzales M, Milliez J, et al. Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy. European journal of obstetrics, gynecology, and reproductive biology. 2004;114(2):125-9.
Fehr T, Cathomas G, Weber C, Fontana A, Schaffner AJL. Foetal loss, liver necrosis and acute lupus erythematosus in a patient with antiphospholipid antibody syndrome. 2001;10(8):576-9.
Silver RM, Parker CB, Reddy UM, Goldenberg R, Coustan D, Dudley DJ, et al. Antiphospholipid antibodies in stillbirth. 2013;122(3):641.
Rodrigues VO, Soligo A, Pannain GD. Antiphospholipid Antibody Syndrome and Infertility. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2019;41(10):621-7.
El Hasbani G, Khamashta M, Uthman I. Antiphospholipid syndrome and infertility. Lupus. 2020;29(2):105-17.
Schreiber K, Hunt BJ. Managing antiphospholipid syndrome in pregnancy. Thrombosis research. 2019;181 Suppl 1:S41-s6.
Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet (London, England). 2010;376(9751):1498-509.
Schreiber K, Hunt BJ. Pregnancy and Antiphospholipid Syndrome. Seminars in thrombosis and hemostasis. 2016;42(7):780-8.
Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):844s-86s.
Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstetrics and gynecology. 2002;99(1):135-44.